The big news: Clearlake Capital announced that it had acquired a majority stake in ModMed, a healthcare SaaS platform, from Warburg Pincus in a deal that values the company at a reported $5.3 billion. Financial terms were not disclosed.
On the move: Trent Green, the CEO of Amazon’s One Medical consumer health care company, announced that he was departing the role. Green will become the CEO of the National Research Corporation, a healthcare improvement organization. Green will succeed Mike Hays, the company’s current CEO, who will transition to the role of Chairman,
The buzz: Several major announcements were made at the annual HIMSS conference in Las Vegas, including the news that health software company Epic is developing an enterprise resource planning platform for health care systems. The Clinical Trials Management System will unify trial workflows for patients, clinicians, researchers, and administrators and put the company in direct competition with Oracle and Workday.
On the rise: Callio Therapeutics, a biotech company, launched with a $187 million Series A with significant participation from Jeito Capital alongside other life sciences investors. Callio is focused on realizing the promise of multi-payload antibody-drug conjugates to improve cancer therapy.
What’s next: Epredia, a precision cancer diagnostics company and subsidiary of PHC Holdings Corporation, announced FDA clearance for its E1000 Dx Digital Pathology Solution, a high-speed, automated, whole-slide imaging digital scanner with medical grade viewer and advanced image management and viewer software that creates high-resolution digital images of up to 1,500 tissue samples daily.
